JANE STREET GROUP, LLC - MANNKIND CORP ownership

MANNKIND CORP's ticker is MNKDXXXX and the CUSIP is 56400P201. A total of 186 filers reported holding MANNKIND CORP in Q4 2015. The put-call ratio across all filers is 1.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of MANNKIND CORP
ValueSharesWeighting
Q4 2016$123,000
+70.8%
192,681
+67.0%
0.00%
Q3 2016$72,000
+12.5%
115,384
+110.4%
0.00%
Q2 2016$64,000
-81.8%
54,845
-74.8%
0.00%
-100.0%
Q1 2016$351,000
-75.4%
218,005
-77.9%
0.00%
-77.8%
Q4 2015$1,428,000
+5.7%
984,990
+134.1%
0.01%
+12.5%
Q3 2015$1,351,000
-26.6%
420,722
+30.1%
0.01%
-33.3%
Q2 2015$1,840,000
+155.6%
323,368
+133.7%
0.01%
+100.0%
Q1 2015$720,000
+228.8%
138,381
+229.9%
0.01%
+200.0%
Q4 2014$219,000
-84.8%
41,951
-68.1%
0.00%
-88.9%
Q2 2014$1,441,000
+1575.6%
131,485
+514.1%
0.02%
+1700.0%
Q1 2014$86,00021,4100.00%
Other shareholders
MANNKIND CORP shareholders Q4 2015
NameSharesValueWeighting ↓
Greywolf Capital Management LP 7,206,570$37,582,0006.66%
AYM CAPITAL, LLC 1,417,300$7,392,0005.50%
AYM CAPITAL, LLC 655,000$3,416,0002.54%
TENOR CAPITAL MANAGEMENT Co., L.P. 1,810,250$9,440,0002.51%
Beach Point Capital Management LP 1,902,100$9,919,0002.37%
Cohen Capital Management, Inc. 503,000$2,623,0000.68%
Tourbillon Capital Partners, L.P. 3,300,000$17,210,0000.46%
EQUITEC SPECIALISTS, LLC 288,700$1,504,0000.39%
Old West Investment Management, LLC 116,676$608,0000.38%
Adamant Biomedical Investments AG 300,000$1,564,0000.37%
View complete list of MANNKIND CORP shareholders